In vitro quality of whole blood‐derived red cell concentrates collected, processed and stored in a blood bag set plasticized with di (2‐ethylhexyl) terephthalate
Vox Sanguinis · 2025
DOI: 10.1111/vox.70087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vox Sanguinis, 2025. Verfasst von Tatiana Stephenson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Product and Process Development, Canadian Blood Services, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Erythrocytes, Blood Preservation, Diethylhexyl Phthalate, Plasticizers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Objectives Due to toxicity concerns, di(2‐ethylhexyl) phthalate (DEHP)—the most used plasticizer in polyvinyl chloride (PVC) whole blood (WB) collection and processing bag sets—will be effectively prohibited in medical devices in Europe from 2030. Removal of DEHP will primarily impact the in vitro quality of red blood cell (RBC) concentrates (RCCs) and DEHP‐free sets with alternate additive solutions (ASs) that better preserve RBCs in the absence of DEHP are being developed. This study compared the in vitro quality of RCCs from di (2‐ethylhexyl) terephthalate (DEHT)/phosphate‐adenine‐glucose‐guanosine‐saline‐mannitol (PAGGSM) and DEHP/saline‐adenine‐glucose‐mannitol (SAGM) sets. Materials and Methods WB was collected into citrate‐phosphate‐dextrose (CPD) in either 500‐mL DEHP/SAGM ( n = 37) or prototype 475‐mL DEHT/PAGGSM bag sets ( n = 29). Leucoreduced (LR)‐RCCs were produced using semi‐automated top/bottom processing within 24 h of collection. RBC quality, including haemolysis, supernatant metabolic parameters and RBC deformability, was measured on D43 (1‐day after expiry). Results All RCCs in the study had haemolysis
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Product and Process Development, Canadian Blood Services, Vancouver, British Columbia, Canada.
- Product and Process Development, Canadian Blood Services, Edmonton, Alberta, Canada.
- Clinical Regulatory Affairs, Macopharma, Mouvaux, France.
- Research and Development, Macopharma, Mouvaux, France.
- Product and Process Development, Canadian Blood Services, Ottawa, Ontario, Canada.
ORCID-Profile: Geraldine M Walsh
Zitieren
APA
Stephenson, T., Howell, A., Olafson, C., Sumian, C., Reichenberg, S., Brebant, Q., McTaggart, K., & Walsh, G. M. (2025). In vitro quality of whole blood‐derived red cell concentrates collected, processed and stored in a blood bag set plasticized with di (2‐ethylhexyl) terephthalate. Vox Sanguinis. https://doi.org/10.1111/vox.70087
Vancouver
Stephenson T, Howell A, Olafson C, Sumian C, Reichenberg S, Brebant Q, et al. In vitro quality of whole blood‐derived red cell concentrates collected, processed and stored in a blood bag set plasticized with di (2‐ethylhexyl) terephthalate. Vox Sanguinis. 2025. doi:10.1111/vox.70087
BibTeX
@article{Stephenson2025,
author = {Stephenson, Tatiana and Howell, Anita and Olafson, Carly and Sumian, Chryslain and Reichenberg, Stefan and Brebant, Quentin and McTaggart, Ken and Walsh, Geraldine M},
title = {In vitro quality of whole blood‐derived red cell concentrates collected, processed and stored in a blood bag set plasticized with di (2‐ethylhexyl) terephthalate},
journal = {Vox Sanguinis},
year = {2025},
doi = {10.1111/vox.70087}
}
EUVIMED